SA
Sign upLog In

Novartis AG Common Stock (NVS)

SG&A Expenses

$13.13B

TTM · Period ending: · USD

NVS logo

NVS SG&A Expenses

Latest reported$13.13B
NVS TTM SG&A Expenses ($1.65B → $13.13B)
High-resolution chart · PNG

NVS sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Novartis AG Common Stock SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
1,720,000,000
1,647,000,000
1,647,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.